Suppr超能文献

抗黏附分子-1 偶联纳米载体递呈量子点实现炎症性肠病的特异性成像。

Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease.

机构信息

Nanomedicine and Molecular Imaging Laboratory, Istituti Clinici Scientifici Maugeri IRCCS, Pavia 27100, Italy.

Department of Biomedical and Clinical Sciences "Luigi Sacco, Università degli studi di Milano, Milano, 20157, Italy.

出版信息

Int J Nanomedicine. 2020 Nov 2;15:8537-8552. doi: 10.2147/IJN.S264513. eCollection 2020.

Abstract

PURPOSE

Assessment of inflammatory bowel disease (IBD) currently relies on aspecific clinical signs of bowel inflammation. Specific imaging of the diseased bowel regions is still lacking. Here, we investigate mucosal addressin cell adhesion molecule 1 (MAdCAM-1) as a reliable and specific endothelial target for engineered nanoparticles delivering imaging agents to obtain an exact mapping of diseased bowel foci.

MATERIALS AND METHODS

We generated a nanodevice composed of PLGA-PEG coupled with anti-MAdCAM-1 antibody half-chains and loaded with quantum dots (P@QD-MdC NPs). Bowel localization and systemic biodistribution of the nanoconjugate were analyzed upon injection in a murine model of chronic IBD obtained through repeated administration of dextran sulfate sodium salt. Specificity for diseased bowel regions was also assessed ex vivo in human specimens from patients with IBD. Potential for development as contrast agent in magnetic resonance imaging was assessed by preliminary study on animal model.

RESULTS

Synthesized nanoparticles revealed good stability and monodispersity. Molecular targeting properties were analyzed in vitro in a cell culture model. Upon intravenous injection, P@QD-MdC NPs were localized in the bowel of colitic mice, with enhanced accumulation at 24 h post-injection compared to untargeted nanoparticles (p<0.05). Nanoparticles injection did not induce histologic lesions in non-target organs. Ex vivo exposure of human bowel specimens to P@QD-MdC NPs revealed specific recognition of the diseased regions vs uninvolved tracts (p<0.0001). After loading with appropriate contrast agent, the nanoparticles enabled localized contrast enhancement of bowel mucosa in the rectum of treated mice.

CONCLUSION

P@QD-MdC NPs efficiently detected bowel inflammation foci, accurately following the expression pattern of MAdCAM-1. Fine-tuning of this nanoconjugate with appropriate imaging agents offers a promising non-invasive tool for specific IBD diagnosis.

摘要

目的

目前,炎症性肠病(IBD)的评估依赖于肠道炎症的特定临床体征。对患病肠道区域的特定成像仍然缺乏。在这里,我们研究了粘膜地址素细胞黏附分子 1(MAdCAM-1)作为一种可靠和特异的内皮靶点,用于将成像剂递送至工程纳米颗粒,以获得患病肠焦点的精确映射。

材料和方法

我们生成了一种由 PLGA-PEG 偶联抗 MAdCAM-1 抗体半链和量子点(P@QD-MdC NPs)组成的纳米器件。通过在反复给予葡聚糖硫酸钠盐的慢性 IBD 小鼠模型中注射,分析了纳米复合物的肠道定位和系统生物分布。还在 IBD 患者的人标本中进行了体外评估,以评估其对患病肠道区域的特异性。通过对动物模型的初步研究,评估了作为磁共振成像对比剂的潜力。

结果

合成的纳米粒子显示出良好的稳定性和单分散性。在体外细胞培养模型中分析了分子靶向特性。静脉注射后,P@QD-MdC NPs 被定位在结肠炎小鼠的肠道中,与未靶向的纳米粒子相比,在注射后 24 小时的积累增加(p<0.05)。纳米粒子注射不会在非靶向器官中引起组织学损伤。在体外暴露于 P@QD-MdC NPs 的人肠标本中,与未受累的节段相比,病变部位有特异性识别(p<0.0001)。用适当的对比剂加载后,纳米颗粒能够在治疗小鼠的直肠中局部增强肠黏膜的对比度。

结论

P@QD-MdC NPs 有效地检测了肠道炎症病灶,准确地遵循了 MAdCAM-1 的表达模式。用适当的成像剂对这种纳米复合物进行微调,为 IBD 的特异性诊断提供了一种有前途的非侵入性工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/891d/7646444/36b61d4dbf83/IJN-15-8537-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验